DK143249C - Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa - Google Patents

Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa

Info

Publication number
DK143249C
DK143249C DK42677A DK42677A DK143249C DK 143249 C DK143249 C DK 143249C DK 42677 A DK42677 A DK 42677A DK 42677 A DK42677 A DK 42677A DK 143249 C DK143249 C DK 143249C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
pseudomonas aeruginosa
therapeutic application
gamma globulin
Prior art date
Application number
DK42677A
Other languages
English (en)
Other versions
DK143249B (da
DK42677A (da
Inventor
Y Homma
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of DK42677A publication Critical patent/DK42677A/da
Publication of DK143249B publication Critical patent/DK143249B/da
Application granted granted Critical
Publication of DK143249C publication Critical patent/DK143249C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK42677A 1976-02-05 1977-02-02 Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa DK143249C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1086676 1976-02-05
JP1086676A JPS5296731A (en) 1976-02-05 1976-02-05 Prophylactics and remedies of cyanomycosis

Publications (3)

Publication Number Publication Date
DK42677A DK42677A (da) 1977-08-06
DK143249B DK143249B (da) 1981-08-03
DK143249C true DK143249C (da) 1981-11-30

Family

ID=11762262

Family Applications (1)

Application Number Title Priority Date Filing Date
DK42677A DK143249C (da) 1976-02-05 1977-02-02 Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa

Country Status (7)

Country Link
US (1) US4120950A (da)
JP (1) JPS5296731A (da)
AT (1) AT343798B (da)
DE (1) DE2639012C3 (da)
DK (1) DK143249C (da)
FR (1) FR2361905A1 (da)
GB (1) GB1545862A (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
CA1247527A (en) * 1983-06-14 1988-12-28 Michael S. Collins High titer pseudomonas immune serum globulin
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
DE3508384A1 (de) * 1985-03-08 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
US4772465A (en) * 1986-10-27 1988-09-20 Miles Laboratories, Inc. Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin
ES2815628T3 (es) * 2015-02-20 2021-03-30 Roal Oy Métodos para controlar la producción de proteasas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947575A (en) * 1969-06-30 1976-03-30 E. R. Squibb & Sons, Inc. Peptides as argiotensin converting enzyme inhibitors
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum

Also Published As

Publication number Publication date
DK143249B (da) 1981-08-03
US4120950A (en) 1978-10-17
JPS5296731A (en) 1977-08-13
DE2639012B2 (de) 1978-08-03
ATA637776A (de) 1977-10-15
DK42677A (da) 1977-08-06
AT343798B (de) 1978-06-12
FR2361905B1 (da) 1981-11-20
GB1545862A (en) 1979-05-16
JPS546608B2 (da) 1979-03-30
DE2639012A1 (de) 1977-08-11
FR2361905A1 (fr) 1978-03-17
DE2639012C3 (de) 1979-06-28

Similar Documents

Publication Publication Date Title
DK183277A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK63877A (da) Fremgangsmade til fremstilling af cephalosporinantibiotika
DK143690C (da) Antiseptisk bandage
DK236275A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK457676A (da) Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser
BE840714A (fr) Filtre a sang
DK457576A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK143249C (da) Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa
DK144753C (da) Fremgangsmaade til fremstilling af en blandingsvaccine mod infektioner af pseudomonas aeruginosa
DK193775A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK73777A (da) Fremgangsmade til fremstilling af antibakterielt virksomme amider
FI781866A (fi) Foerfarande foer framstaellning av terapeutiskt aktiv n-/3-merkaptoacetylamino) bensoyl/ glycin.
DK364177A (da) Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK528777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK152357C (da) Fremgangsmaade til fremstilling af optisk aktive anthracyclinoner
DK223875A (da) Fremgangsmade til fremstilling af antibakterielle midler
SE428469B (sv) Forfarande for framstellning av tertiera aminer.
DK457376A (da) Fremgangsmade til fremstilling af antibakterielt virksomme forbindelser
DK147033C (da) Fremgangsmaade til fremstilling af en vaccine mod panleukopeni hos felider
DK298576A (da) Behandling af bovint mastitis
NO145436C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminer.
DK276377A (da) Fremgangsmade til fremstilling af optisk aktive derivater af benzoxazolylpropionsyre
DK301577A (da) Fremgangsmaade til fremstilling af optisk aktive trans-hexahydrodibenzopyranoner
DK221277A (da) Fremgangsmade til fremstilling af terapeutisk virksomme aminer
DK418676A (da) Fremstilling af kvaternere ammoniumsalte

Legal Events

Date Code Title Description
PBP Patent lapsed